H|T: The Healthtech Times – Toronto biotech secures $2.2M to treat immune diseases
Beta Kit HiLabs, a company that uses AI to manage dirty data, has raised $39 million in Series B funding, the company announced Thursday. Its cloud-based …
Read the original at Toronto biotech secures $2.2M to treat immune diseases ↗
- Topics
- HealthcareMarkets & Investment
- Tags
- AI Use Case
- Tracked via
- Google Alert “that uses AI to”